Press Releases

AsisChem Grows Rapidly in the Second Half of 2006.

Cambridge, MA - 12/15/2006 - AsisChem, Inc., a contract research organization (CRO) providing custom chemistry services to pharmaceutical and biotechnology companies, today reported that it achieved record sales and signed a record number of new customers in the first, second and third quarters of 2006. "We are very excited to be helping biotechnology companies in their drug discovery efforts" said Dr. Ilya Kuchuk, AsisChem's Chief Scientific Officer. "Our chemists synthesized several focused libraries as part of hit-to-lead projects, and our customers are finding success in producing better lead compounds as a result".

AsisChem has grown considerably since inception, and in the last quarter it has added 4 internationally trained chemists to its research and development team. AsisChem's scientists are focused on custom synthesis projects as well as production of building blocks and screening compounds for orders from its large product catalog. Its research and development work is conducted in St. Petersburg, Russia, while it is focused on gaining new clients in the United States.

AsisChem's growth is inline with the overall pharmaceutical industry trend towards greater outsourcing of functions unrelated to biotechnology companies' core competencies. Many small to medium sized biotechnology companies are very focused on the science behind their drug candidates, and are not particularly concerned with specific chemistry problems that the synthesis of these compounds poses. They look to AsisChem and other companies in the CRO industry to leverage its chemistry expertise and solve these problems for them. AsisChem's advantage lies in its ability to provide expert custom chemistry services with the highest level of customer service at prices far below that of its competitors whose research and development operations are based in the US. "We expect to continue to leverage our expertise, attractive pricing and customer focus to establish new scientific collaborations in the second half of 2006" said Dr. Kuchuk. "Even more importantly, we will continue to expand our existing customer relationships that have been built upon successfully completed projects in the past three quarters."

About AsisChem, Inc.
AsisChem is a contract research organization (CRO) providing custom synthesis, medicinal chemistry and other custom chemistry services to pharmaceutical and biotechnology companies internationally. With more then 30 Ph.D. scientists conducting research and development in St. Petersburg, Russia, AsisChem hosts an array of advanced discovery chemistry services and products including a library of over 150,000 diverse drug-like small molecule compounds and over 15,000 advanced building blocks. Headquartered in Cambridge, MA USA AsisChem is privately held. For more information please email info@asischem.com or visit http://www.asischem.com


For further information:

Bryan K. Roland, Ph.D
Business Development Manager
Asischem Inc.
245 First Street, 18th Floor
Cambridge, MA 02142 USA
Toll free: 877.936.6191
Direct: 716.536.0880
Email: bryan.roland@asischem.com
http://www.asischem.com